Pharmacist-implemented intervention to surmount COVID-19 vaccination hesitancy in adults with substance use disorders
American Journal of Health-System Pharmacy · 2024
DOI: 10.1093/ajhp/zxae095 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, 2024. Verfasst von Zoe Karavolis und 6 weiteren Autor:innen. Beteiligte Einrichtung: UPMC Western Psychiatric Hospital, Pittsburgh, PA. Hauptthemen laut MEDLINE: COVID-19, Pharmacists, COVID-19 Vaccines, Substance-Related Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Purpose
Substance use disorders (SUDs) increase the risk and severity of infectious diseases, including coronavirus disease 2019 (COVID-19). Adults with a co-occurring SUD and psychiatric disorder were studied to elucidate the association between SUD severity and (1) COVID-19 vaccination status, (2) receptivity to a one-session intervention with a pharmacist advocating the benefits of vaccination, and (3) acceptance of referral for vaccination following the intervention.
Methods
COVID-19 vaccination status was recorded in 460 adults with SUD (324 males and 136 females) upon entry into inpatient treatment. A 2-parameter item response theory (IRT) model quantified SUD severity. Pharmacist-delivered intervention, modeled after the screening, brief intervention, and referral to treatment (SBIRT) protocol, was offered to unvaccinated participants.
Results
Higher SUD severity was associated with a lower vaccination rate. Nicotine, opioid, and sedative use disorders were most frequently associated with unvaccinated status. SUD severity was not associated with receptivity to intervention advocating vaccination or subsequent acceptance of a referral for vaccination. The portion of the sample that received the intervention was over 7 times more likely to accept a referral for vaccination when compared to participants who rejected the intervention (20.8% vs 2.8%).
Conclusion
Pharmacist-administered intervention produced motivation for vaccination in a number of recipients; however, receptivity to the intervention was not related to SUD severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UPMC Western Psychiatric Hospital, Pittsburgh, PA.
- McLean Hospital, Belmont, MA, USA.
- UPMC Western Psychiatric Hospital, Pittsburgh, PA, USA.
- School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
ORCID-Profile: Zoe Karavolis
Zitieren
APA
Karavolis, Z., Thacker, E., Fabian, T., Douaihy, A., Reynolds, M., Kirisci, L., & Tarter, R. (2024). Pharmacist-implemented intervention to surmount COVID-19 vaccination hesitancy in adults with substance use disorders. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxae095
Vancouver
Karavolis Z, Thacker E, Fabian T, Douaihy A, Reynolds M, Kirisci L, et al. Pharmacist-implemented intervention to surmount COVID-19 vaccination hesitancy in adults with substance use disorders. American Journal of Health-System Pharmacy. 2024. doi:10.1093/ajhp/zxae095
BibTeX
@article{Karavolis2024,
author = {Karavolis, Zoe and Thacker, Emily and Fabian, Tanya and Douaihy, Antoine and Reynolds, Maureen and Kirisci, Levent and Tarter, Ralph},
title = {Pharmacist-implemented intervention to surmount COVID-19 vaccination hesitancy in adults with substance use disorders},
journal = {American Journal of Health-System Pharmacy},
year = {2024},
doi = {10.1093/ajhp/zxae095}
}
EUVIMED